PharmaShots | Incisive News in 3 Shots

Subscribe Now

IV

GSK Reports Results of Benlysta (belimumab- IV) in P-III BLISS-LN Study for Patients with Active Lupus Nephritis

GSK Reports Results of Benlysta (belimumab- IV) in P-III BLISS-LN Study for Patients with Active Lupus Nephritis

December 19, 2019

Athersys Reports Results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS)

Athersys Reports Results of Multistem Cell Therapy (IV) in Patients with Acute Respiratory Distress Syndrome (ARDS)

January 24, 2019

Shire's Takhzyro IV (lanadelumab) Receives EU's Approval for Hereditary Angioedema

Shire's Takhzyro IV (lanadelumab) Receives EU's Approval for Hereditary Angioedema

December 3, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us